Oligonucleotide Synthesis-Europe Market Status and Trend Report 2013-2023
Report Summary
Oligonucleotide Synthesis-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oligonucleotide Synthesis industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Oligonucleotide Synthesis 2013-2017, and development forecast 2018-2023
Main market players of Oligonucleotide Synthesis in Europe, with company and product introduction, position in the Oligonucleotide Synthesis market
Market status and development trend of Oligonucleotide Synthesis by types and applications
Cost and profit status of Oligonucleotide Synthesis, and marketing status
Market growth drivers and challenges
The report segments the Europe Oligonucleotide Synthesis market as:
Europe Oligonucleotide Synthesis Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Oligonucleotide Synthesis Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Primer
Probe
Reagent
Europe Oligonucleotide Synthesis Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Academic
Pharmaceutical
Biotechnology
Europe Oligonucleotide Synthesis Market: Players Segment Analysis (Company and Product introduction, Oligonucleotide Synthesis Sales Volume, Revenue, Price and Gross Margin):
INTEGRATED DNA TECHNOLOGIES, INC.
MERCK KGAA
EUROFINS GENOMICS
THERMO FISHER SCIENTIFIC INC.
BIOAUTOMATION CORPORATION
AGILENT TECHNOLOGIES, INC.
EUROGENTEC S.A.
GENERAL ELECTRIC (GE) COMPANY
LGC BIOSEARCH TECHNOLOGIES, INC.
NITTO DENKO AVECIA INC.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oligonucleotide Synthesis-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oligonucleotide Synthesis industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Oligonucleotide Synthesis 2013-2017, and development forecast 2018-2023
Main market players of Oligonucleotide Synthesis in Europe, with company and product introduction, position in the Oligonucleotide Synthesis market
Market status and development trend of Oligonucleotide Synthesis by types and applications
Cost and profit status of Oligonucleotide Synthesis, and marketing status
Market growth drivers and challenges
The report segments the Europe Oligonucleotide Synthesis market as:
Europe Oligonucleotide Synthesis Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Oligonucleotide Synthesis Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Primer
Probe
Reagent
Europe Oligonucleotide Synthesis Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Academic
Pharmaceutical
Biotechnology
Europe Oligonucleotide Synthesis Market: Players Segment Analysis (Company and Product introduction, Oligonucleotide Synthesis Sales Volume, Revenue, Price and Gross Margin):
INTEGRATED DNA TECHNOLOGIES, INC.
MERCK KGAA
EUROFINS GENOMICS
THERMO FISHER SCIENTIFIC INC.
BIOAUTOMATION CORPORATION
AGILENT TECHNOLOGIES, INC.
EUROGENTEC S.A.
GENERAL ELECTRIC (GE) COMPANY
LGC BIOSEARCH TECHNOLOGIES, INC.
NITTO DENKO AVECIA INC.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OLIGONUCLEOTIDE SYNTHESIS
1.1 Definition of Oligonucleotide Synthesis in This Report
1.2 Commercial Types of Oligonucleotide Synthesis
1.2.1 Primer
1.2.2 Probe
1.2.3 Reagent
1.3 Downstream Application of Oligonucleotide Synthesis
1.3.1 Academic
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Development History of Oligonucleotide Synthesis
1.5 Market Status and Trend of Oligonucleotide Synthesis 2013-2023
1.5.1 Europe Oligonucleotide Synthesis Market Status and Trend 2013-2023
1.5.2 Regional Oligonucleotide Synthesis Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oligonucleotide Synthesis in Europe 2013-2017
2.2 Consumption Market of Oligonucleotide Synthesis in Europe by Regions
2.2.1 Consumption Volume of Oligonucleotide Synthesis in Europe by Regions
2.2.2 Revenue of Oligonucleotide Synthesis in Europe by Regions
2.3 Market Analysis of Oligonucleotide Synthesis in Europe by Regions
2.3.1 Market Analysis of Oligonucleotide Synthesis in Germany 2013-2017
2.3.2 Market Analysis of Oligonucleotide Synthesis in United Kingdom 2013-2017
2.3.3 Market Analysis of Oligonucleotide Synthesis in France 2013-2017
2.3.4 Market Analysis of Oligonucleotide Synthesis in Italy 2013-2017
2.3.5 Market Analysis of Oligonucleotide Synthesis in Spain 2013-2017
2.3.6 Market Analysis of Oligonucleotide Synthesis in Benelux 2013-2017
2.3.7 Market Analysis of Oligonucleotide Synthesis in Russia 2013-2017
2.4 Market Development Forecast of Oligonucleotide Synthesis in Europe 2018-2023
2.4.1 Market Development Forecast of Oligonucleotide Synthesis in Europe 2018-2023
2.4.2 Market Development Forecast of Oligonucleotide Synthesis by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Oligonucleotide Synthesis in Europe by Types
3.1.2 Revenue of Oligonucleotide Synthesis in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Oligonucleotide Synthesis in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oligonucleotide Synthesis in Europe by Downstream Industry
4.2 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Germany
4.2.2 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in France
4.2.4 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Italy
4.2.5 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Spain
4.2.6 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Benelux
4.2.7 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Russia
4.3 Market Forecast of Oligonucleotide Synthesis in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
5.1 Europe Economy Situation and Trend Overview
5.2 Oligonucleotide Synthesis Downstream Industry Situation and Trend Overview
CHAPTER 6 OLIGONUCLEOTIDE SYNTHESIS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Oligonucleotide Synthesis in Europe by Major Players
6.2 Revenue of Oligonucleotide Synthesis in Europe by Major Players
6.3 Basic Information of Oligonucleotide Synthesis by Major Players
6.3.1 Headquarters Location and Established Time of Oligonucleotide Synthesis Major Players
6.3.2 Employees and Revenue Level of Oligonucleotide Synthesis Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OLIGONUCLEOTIDE SYNTHESIS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 INTEGRATED DNA TECHNOLOGIES, INC.
7.1.1 Company profile
7.1.2 Representative Oligonucleotide Synthesis Product
7.1.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of INTEGRATED DNA TECHNOLOGIES, INC.
7.2 MERCK KGAA
7.2.1 Company profile
7.2.2 Representative Oligonucleotide Synthesis Product
7.2.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of MERCK KGAA
7.3 EUROFINS GENOMICS
7.3.1 Company profile
7.3.2 Representative Oligonucleotide Synthesis Product
7.3.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of EUROFINS GENOMICS
7.4 THERMO FISHER SCIENTIFIC INC.
7.4.1 Company profile
7.4.2 Representative Oligonucleotide Synthesis Product
7.4.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC INC.
7.5 BIOAUTOMATION CORPORATION
7.5.1 Company profile
7.5.2 Representative Oligonucleotide Synthesis Product
7.5.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of BIOAUTOMATION CORPORATION
7.6 AGILENT TECHNOLOGIES, INC.
7.6.1 Company profile
7.6.2 Representative Oligonucleotide Synthesis Product
7.6.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES, INC.
7.7 EUROGENTEC S.A.
7.7.1 Company profile
7.7.2 Representative Oligonucleotide Synthesis Product
7.7.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of EUROGENTEC S.A.
7.8 GENERAL ELECTRIC (GE) COMPANY
7.8.1 Company profile
7.8.2 Representative Oligonucleotide Synthesis Product
7.8.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of GENERAL ELECTRIC (GE) COMPANY
7.9 LGC BIOSEARCH TECHNOLOGIES, INC.
7.9.1 Company profile
7.9.2 Representative Oligonucleotide Synthesis Product
7.9.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of LGC BIOSEARCH TECHNOLOGIES, INC.
7.10 NITTO DENKO AVECIA INC.
7.10.1 Company profile
7.10.2 Representative Oligonucleotide Synthesis Product
7.10.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of NITTO DENKO AVECIA INC.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
8.1 Industry Chain of Oligonucleotide Synthesis
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
9.1 Cost Structure Analysis of Oligonucleotide Synthesis
9.2 Raw Materials Cost Analysis of Oligonucleotide Synthesis
9.3 Labor Cost Analysis of Oligonucleotide Synthesis
9.4 Manufacturing Expenses Analysis of Oligonucleotide Synthesis
CHAPTER 10 MARKETING STATUS ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Oligonucleotide Synthesis in This Report
1.2 Commercial Types of Oligonucleotide Synthesis
1.2.1 Primer
1.2.2 Probe
1.2.3 Reagent
1.3 Downstream Application of Oligonucleotide Synthesis
1.3.1 Academic
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Development History of Oligonucleotide Synthesis
1.5 Market Status and Trend of Oligonucleotide Synthesis 2013-2023
1.5.1 Europe Oligonucleotide Synthesis Market Status and Trend 2013-2023
1.5.2 Regional Oligonucleotide Synthesis Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oligonucleotide Synthesis in Europe 2013-2017
2.2 Consumption Market of Oligonucleotide Synthesis in Europe by Regions
2.2.1 Consumption Volume of Oligonucleotide Synthesis in Europe by Regions
2.2.2 Revenue of Oligonucleotide Synthesis in Europe by Regions
2.3 Market Analysis of Oligonucleotide Synthesis in Europe by Regions
2.3.1 Market Analysis of Oligonucleotide Synthesis in Germany 2013-2017
2.3.2 Market Analysis of Oligonucleotide Synthesis in United Kingdom 2013-2017
2.3.3 Market Analysis of Oligonucleotide Synthesis in France 2013-2017
2.3.4 Market Analysis of Oligonucleotide Synthesis in Italy 2013-2017
2.3.5 Market Analysis of Oligonucleotide Synthesis in Spain 2013-2017
2.3.6 Market Analysis of Oligonucleotide Synthesis in Benelux 2013-2017
2.3.7 Market Analysis of Oligonucleotide Synthesis in Russia 2013-2017
2.4 Market Development Forecast of Oligonucleotide Synthesis in Europe 2018-2023
2.4.1 Market Development Forecast of Oligonucleotide Synthesis in Europe 2018-2023
2.4.2 Market Development Forecast of Oligonucleotide Synthesis by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Oligonucleotide Synthesis in Europe by Types
3.1.2 Revenue of Oligonucleotide Synthesis in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Oligonucleotide Synthesis in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oligonucleotide Synthesis in Europe by Downstream Industry
4.2 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Germany
4.2.2 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in France
4.2.4 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Italy
4.2.5 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Spain
4.2.6 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Benelux
4.2.7 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Russia
4.3 Market Forecast of Oligonucleotide Synthesis in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
5.1 Europe Economy Situation and Trend Overview
5.2 Oligonucleotide Synthesis Downstream Industry Situation and Trend Overview
CHAPTER 6 OLIGONUCLEOTIDE SYNTHESIS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Oligonucleotide Synthesis in Europe by Major Players
6.2 Revenue of Oligonucleotide Synthesis in Europe by Major Players
6.3 Basic Information of Oligonucleotide Synthesis by Major Players
6.3.1 Headquarters Location and Established Time of Oligonucleotide Synthesis Major Players
6.3.2 Employees and Revenue Level of Oligonucleotide Synthesis Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OLIGONUCLEOTIDE SYNTHESIS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 INTEGRATED DNA TECHNOLOGIES, INC.
7.1.1 Company profile
7.1.2 Representative Oligonucleotide Synthesis Product
7.1.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of INTEGRATED DNA TECHNOLOGIES, INC.
7.2 MERCK KGAA
7.2.1 Company profile
7.2.2 Representative Oligonucleotide Synthesis Product
7.2.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of MERCK KGAA
7.3 EUROFINS GENOMICS
7.3.1 Company profile
7.3.2 Representative Oligonucleotide Synthesis Product
7.3.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of EUROFINS GENOMICS
7.4 THERMO FISHER SCIENTIFIC INC.
7.4.1 Company profile
7.4.2 Representative Oligonucleotide Synthesis Product
7.4.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC INC.
7.5 BIOAUTOMATION CORPORATION
7.5.1 Company profile
7.5.2 Representative Oligonucleotide Synthesis Product
7.5.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of BIOAUTOMATION CORPORATION
7.6 AGILENT TECHNOLOGIES, INC.
7.6.1 Company profile
7.6.2 Representative Oligonucleotide Synthesis Product
7.6.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES, INC.
7.7 EUROGENTEC S.A.
7.7.1 Company profile
7.7.2 Representative Oligonucleotide Synthesis Product
7.7.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of EUROGENTEC S.A.
7.8 GENERAL ELECTRIC (GE) COMPANY
7.8.1 Company profile
7.8.2 Representative Oligonucleotide Synthesis Product
7.8.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of GENERAL ELECTRIC (GE) COMPANY
7.9 LGC BIOSEARCH TECHNOLOGIES, INC.
7.9.1 Company profile
7.9.2 Representative Oligonucleotide Synthesis Product
7.9.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of LGC BIOSEARCH TECHNOLOGIES, INC.
7.10 NITTO DENKO AVECIA INC.
7.10.1 Company profile
7.10.2 Representative Oligonucleotide Synthesis Product
7.10.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of NITTO DENKO AVECIA INC.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
8.1 Industry Chain of Oligonucleotide Synthesis
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
9.1 Cost Structure Analysis of Oligonucleotide Synthesis
9.2 Raw Materials Cost Analysis of Oligonucleotide Synthesis
9.3 Labor Cost Analysis of Oligonucleotide Synthesis
9.4 Manufacturing Expenses Analysis of Oligonucleotide Synthesis
CHAPTER 10 MARKETING STATUS ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
